NPI: 1164484234 · SANTEE, SC 29142 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,344 | $133K |
| 2019 | 7,778 | $153K |
| 2020 | 10,444 | $128K |
| 2021 | 5,394 | $73K |
| 2022 | 3,401 | $58K |
| 2023 | 1,528 | $29K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 16,698 | 1,542 | $532K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 3,981 | 591 | $32K |
| A4657 | Syringe, with or without needle, each | 1,589 | 818 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 1,655 | 491 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,240 | 600 | $1K |
| 90674 | 35 | 29 | $205.61 | |
| 83970 | 219 | 192 | $189.40 | |
| 82728 | 188 | 176 | $108.64 | |
| 83550 | 190 | 176 | $83.93 | |
| 82108 | 136 | 132 | $69.74 | |
| 83540 | 190 | 176 | $64.71 | |
| 85041 | 502 | 459 | $52.78 | |
| 85048 | 467 | 435 | $51.05 | |
| 85045 | 247 | 230 | $22.83 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 41 | 39 | $17.02 |
| 90662 | 12 | 12 | $3.82 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 487 | 54 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 12 | 12 | $0.00 |